5
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Renal Involvement in Igd Myeloma

, , , , , , , & show all
Pages 309-312 | Received 06 Apr 1987, Published online: 15 Feb 2010

REFERENCES

  • Casanova S, Pasquali S, Donini U et al. Renal lesions in IgD myeloma: clinical and histological correlations. Giornale Italiano di Nefrologia (Eng. abstr.) 1986; I: 17–25.
  • Chronic Leukemia-Myeloma Task Force, National Cancer Institute: Proposed guidelines for protocol studies. II. Plasma cell myeloma. Cancer Chemoter Rep 1973; 4: 145–158.
  • Clyne DH, Pesce AJ, Thompson RE. Nephrotoxicity of Bence-Jones proteins in the rat: importance of protein isoelectric point. Kidney Int 1979; 16: 345–352.
  • Coward RA, Delamore JW, Mallick NP et al. The importance of urinary immunoglobulin light chain isoelectric point (pl) in nephrotoxicity in multiple myeloma. Clin Sci 1984; 66: 229–232.
  • Fahey JL, Carbone PP, Rowe DS et al. Plasma cell myeloma with D-myeloma protein (IgD-myeloma). Am J Med 1968; 45: 373–380.
  • Fang LST. Light-chain nephropathy. Kidney Int 1985; 27: 582–592.
  • Fibbe WE, Jansen J. Prognostic factors in IgD myeloma: a study of 21 cases. Scand J Haematol 1984; 33: 471–475.
  • Hobbs JR, Corbett AA. Younger age of presentation and extraosseous tumor in IgD myelomatosis. Br Med J 1969; 1: 412–414.
  • Jancelewicz Z, Takatsuki K, Sugai S et al. IgD multiple myeloma. Arch Intern Med 1975; 135: 87–93.
  • Lupo A, Banfi G, Barbiano di Belgiojoso et al. Chronic renal failure in patients with myeloma. Giornale Italiano di Nefrologia (Eng. abstr.) 1986; 1: 39–45.
  • Pruzanski W, Rother I. IgD plasma cell neoplasia: clinical manifestation and characteristic features. Canad Med Ass J 1970; 102: 1061–1065.
  • Virgolini G, Guido Sala P, Tonutti E et al. IgD-myeloma. A study of four cases. Hematologica 1985; 70: 523–526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.